1. Edwards, CM., Heptinstall, S., and Lowe, K.C. Inhibitory effects of the co-polymer surfactant, Pluronic F-68, on spontaneous platelet aggregation in human whole blood. Br. J. Pharmacol. 116, 159P (1995).
2. Edwards, CM., May, J.A. Heptinstall, S., and Lowe, K.C Effects of Pluronic® F-68 (Poloxamer 188) on platelet aggregation in human whole blood. Thromb. Res. 81, 511–512 (1996).
3. Gershlick, A.H., Spriggins, D., Davies, S.W., Syndercombe Court, Y.D., Timmins, J., Timmis, A.D., Rothman, M.T., Layton, C, and Balcon R. Failure of Epoprostanol (prostacyclin, PGI2) to inhibit platelet-aggregation and to prevent restenosis after coronary angioplasty. Results of a randomised placebo-controlled trial. Br. Heart J. 77, 7–15 (1995).
4. Jouani, M.A., Szonyi, F., Trabelsi, H., and Cambon, A. Synthèse de tensioactifs non ioniques F-alkylés polyhydroxylés. Bull. Soc. Chim. Fr. 131, 173–176(1994).
5. Kissa, E. Fluorinated Surfactants. Synthesis, Properties, Applications, Marcel Dekker, New York (1993).